To evaluate the effect of anti-hypertensive medication on efficiency of primary aldosteronism screening test, and to determine the appropriate diagnostic cutoff valuefor Chinese hypertension patients during antihypertensive drugs therapy.
Aldosterone-Renin ratio (ARR)is currently the most reliable means available for screening for primary aldosteronePA. However, some antihypertensive drugs may cause false positives and false negatives on ARR. Thus, America PA guidelines suggest that antihypertensive drugs should be withdraw or change therapy before screening.
But withdraw/changing the therapy before ARR is inconvenient for patients.
we prepare to start a prospective study through recruiting hypertension patients who needs ARR screening test, completing the ARR screening before and after withdraw/change therapy.
| Condition | Vascular Diseases, Hyperaldosteronism, Elevated Blood Pressure, high blood pressure, conn, Diabetes and Hypertension, High Blood Pressure (Hypertension), primary aldosteronism, Hypertension, arterial hypertension, High Blood Pressure (Hypertension - Pediatric), primary hyperaldosteronism |
|---|---|
| Treatment | withdraw antihypertensive drugs |
| Clinical Study Identifier | NCT04991961 |
| Sponsor | Chongqing Medical University |
| Last Modified on | 25 January 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.